Legal Representation
Attorney
Ilene B. Tannen
USPTO Deadlines
Next Deadline
144 days remaining
Statement of Use Due - Extension 4 Granted
Due Date
November 30, 2025
Extension Available
Until May 30, 2024
Application History
33 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 23, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 23, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jun 23, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 12, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED |
| May 12, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 12, 2025 | EXT4 | S | SOU EXTENSION 4 FILED |
| Nov 18, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Nov 18, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 23, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| May 23, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| May 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 21, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 17, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 17, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 30, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 2, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 1, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 10, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 10, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 10, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 6, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 4, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention and treatment of cancer, retinal, liver, metabolic, autoimmune, cardiovascular, neurological, immune, musculoskeletal, endocrine and hematological diseases and disorders
Class 042
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Class 044
Providing medical information relating to cancer, retinal diseases and liver and metabolic diseases
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"